Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services.
Unichem Laboratories Limited (UNICHEMLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The UNICHEMLAB share price is ₹509.15 (+0.92% today), with a market capitalisation of ₹36B and a price-to-earnings (P/E) ratio of 11.8. MarketRipple tracks the UNICHEMLAB investment thesis, the ripple-chain impact of market events on Unichem Laboratories Limited, and the Healthcare sector outlook.
Open
₹501.70
High
₹526.95
Low
₹500.45
Prev. Close
₹504.50
52W High
₹687.20
52W Low
₹278.20
Day range
₹500.45–₹526.95
52-week range
₹278.20–₹687.20
Volume
51K
P/E
11.8
ROE
13.0%
D/E
0.18
Margin
14.3%
Unichem Laboratories Limited (NSE: UNICHEMLAB) is currently trading at ₹509.15 (+0.92%).
Unichem Laboratories Limited's market capitalization is ₹36B.
Unichem Laboratories Limited's price-to-earnings (P/E) ratio is 11.8.
Unichem Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).